The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
LPS Challenge in D-galactosamine–Sensitized Mice Accounts for Caspase-dependent Fulminant Hepatitis, not for Septic Shock
Abstract
Experimental models of sepsis using endotoxin challenges, including studies with sensitized animals with D-galactosamine, have largely contributed to the basic rationale for innovative clinical trials in human septic shock, which have, to date, failed. The ability of these models to reproduce human disease has been highly discussed. We report here that the widely used D-galactosamine/LPS model does not account for septic shock. Treatment with YVAD-CMK, a potent tetrapeptide inhibitor of caspases of the interleukin (IL)-1beta converting enzyme (ICE) family, protects from LPS-induced liver apoptosis and mortality in D-galactosamine-sensitized mice when administered either before or up to 2 h after the lethal challenge. This curative effect is related to complete inhibition of caspase-3 activity in the liver. However, YVAD-CMK does not affect LPS-induced release of IL-1beta and does not protect from a lethal dose of LPS in unsensitized mice. These experiments demonstrate the difference between these two widely recognized experimental models of sepsis. LPS toxicity in D-galactosamine-treated mice, leading to blocked gene transcription, results from tumor necrosis factor (TNF)-alpha-induced caspase-3-dependent liver injury, not from the systemic inflammatory response. These results provide evidence that inhibitors of the ICE caspase family can prevent or even overcome the ongoing hepatic injury induced by TNF-alpha during sepsis, ischemia-reperfusion, or severe hepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M., & Campbell, D. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114656 · Cited by 817 · cited 1×
“The role of TNF-a and Fas (CD95) in several liver diseases is continuously underlined in either septic (32), T-cell‐dependent inflammatory and viral liver injury (8, 33), toxic liver disease (34), ischemia/reperfusion injury ( 35 ), or liver graft rejection (36).”
Background
Cited by
SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation
Qin, H., Holdbrooks, A. T., Liu, Y., Reynolds, S. L., Yanagisawa, L. L., & Benveniste, E. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201168 · Cited by 453
Fauvel, H., Marchetti, P., Chopin, C., Formstecher, P., & Nevière, R. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1608 · Cited by 342
Apoptosis in sepsis: a new target for therapeutic exploration
OBERHOLZER, C., OBERHOLZER, A., CLARE-SALZLER, M., & MOLDAWER, L. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-058rev · Cited by 271
Metadata
- Authors
- MIGNON, A., ROUQUET, N., FABRE, M., MARTIN, S., PAGÈS, J. C., DHAINAUT, J. F., KAHN, A., BRIAND, P., & JOULIN, V.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04-01
- Volume
- 159
- Issue
- 4
- Pages
- 1308-1315
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2051515172
- Cited by
- 177
- References
- 3
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LPS Challenge in D-galactosamine–Sensitized Mice Accounts for Caspase-dependent Fulminant Hepatitis, not for Septic Shock. https://app.cochat.ai/papers/10.1164/ajrccm.159.4.9712012
- The paper
- MIGNON, A., ROUQUET, N., FABRE, M., MARTIN, S., PAGÈS, J. C., DHAINAUT, J. F., KAHN, A., BRIAND, P., & JOULIN, V. (1999). LPS Challenge in D-galactosamine–Sensitized Mice Accounts for Caspase-dependent Fulminant Hepatitis, not for Septic Shock. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.159.4.9712012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.